Ampio pharmaceuticals to present at aspen lung conference

Englewood, colo., july 27, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the company's poster presentation, "inflammation and covid induced ards: inhaled ampion™ as a therapeutic option," being given at the 63rd annual thomas l.

AMPE Ratings Summary

AMPE Quant Ranking